Structural similarities between MGSA and NAP-1/IL-8 . The proteins were aligned according to their four cysteine residues (arrow heads) . Conserved amino acids are boxed.
Results
Activation of Human Neutrophils. The effect of MGSA in inducing exocytosis as assessed by the release ofelastase from azurophil granules was concentration dependent and similar to that of NAP-1/IL-8 ( Fig. 3 a) . Both peptides were effective in the same molar range and elicited a response at the threshold concentration of 3 x 10 -10 M . NAP-1/IL-8 was somewhat more potent (25-35%) than MGSA throughout the range of concentrations tested . NAP-1/1L-8 also induced a rapid and transient respiratory burst response at concentrations of 10-9 to 10 -7 M, confirming former results (6) . By contrast, MGSA showed only borderline activity (Fig. 3 b) . At 10' M, the highest concentration tested, MGSA-stimulated neutrophils produced <2% (<10 pmol) of the H202 obtained with NAP-1/IL-8 .
The data summarized in Table I demonstrate that MGSA is chemotactic as well. Both MGSA and NAP-1/1L-8 induced neutrophil migration in the concentration range of 10 -1°to 10' M, with maximal effects at 10 -8 M. As seen in exocytosis, MGSA was slightly less potent as a chemoattractant than NAP-1/IL-8 .
Like classical chemotactic agonists, such as C5a and fet-Leu-Phe, MGSA induced a transient rise in the concentration of cytosolic-free calcium ([Ca 21],). Calcium mobilization was observed at concentrations as low as 10 -1°M, and a maximal transient elevation was reached at 10 8 M (Fig. 4, inset) . The curves in Fig.  4 , representing the maximal rates in raising [Ca"] ;as a function of MGSA or NAP-1/IL-8 concentration, were virtually identical. The rates in mobilizing cytosolic-free calcium did not reach a plateau in the range of concentrations tested .
In Vivo Effects of MGSA . Light microscopy of skin samples taken 4 h after in-FIGURE 2 . Analysis of purified synthetic MGSA . 15 wl of the purified peptide(1 mg/ml) was loaded onto a Vydac C-18 reverse-phase HPLC column and eluted with a 0-60% water-acetonitrile gradient . The inset represents a silverstained IEF gel of purified MGSA. The gel was equilibrated in 8 M urea, 2% Ampholines pH 8-11, then run and stained using the "PHAST" electrophoresis system (Pharmacia Fine Chemicals, Piscataway, NJ). The pH gradient was determined using a surface pH electrode and positions corresponding to pH 8.0 and 11 .0 are indicated. The pl of MGSA was estimated to be 9.6 (arrow head). tradermal application of MGSA at 10 -9 mol/site demonstrated a massive infiltration of neutrophils (Fig. 5) . No other granulocytes, monocytes, or lymphocytes were detected . The infiltration was most prominent around venules in the deeper dermal layers (Fig . 5 a) , but extended downwards into the subcutis and upwards into the upper dermis . Significant responses of decreasing intensities were obtained with 10 -'°, 10 -", and 10 -' 2 mol/site (data not shown) .
Discussion
This study shows that synthetic MGSA activates and is chemotactic for human neutrophils in vitro and induces massive neutrophil infiltration in vivo . Except for the respiratory burst response, its potency is similar to that of NAP-1/IL-8 . MGSA and NAP-1/IL-8 were prepared by unrelated methods, stepwise chemical synthesis for the former, and expression in Eschenchta colt of a synthetic gene for the latter (6) . Chemical synthesis has established itself as an alternative approach to recombinant technologies for the production of biologically active polypeptides of considerable size, such as IL-3 (8, 9) and the human granulocyte-macrophage CSF (14) . The MGSA preparation was found to be of high purity, and it thus appears unlikely that the effects reported here are due to synthetic byproducts .
The in vitro and in vivo effects reported in this study indicate that MGSA may function as an inflammatory mediator by mechanisms similar to those postulated for NAP-1/1L-8 (3). Recent findings showing that the gene coding for MGSA (gro/MGSA) is expressed in several types of tissue cells supports this hypothesis . Richmond et al. (1) identified MGSA on the basis of its mitogenic activity for Hs294T human melanoma cells. Biochemical and immunocytochemical studies on human melanoma biopsies suggested that MGSA is involved in maintenance of tumor progression . The present study demonstrating the potent neutrophil-activating properties of MGSA indicates that this peptide, in addition to its reported mitogenic activity, may function as a mediator of inflammation .
Summary
Melanoma growth-stimulatory activity (MGSA), a peptide reported to be mitogenic for Hs294T human melanoma cells, has extensive sequence similarity to the neutrophil-activating peptide NAP-1/IL-8, suggesting functional similarities . To test this hypothesis, MGSA was chemically synthesized and tested for its effects on human neutrophils . It was found to induce chemotaxis, exocytosis of elastase, and changes in cytosolic-free calcium to an extent and at concentrations similar to NAP-1/IL-8. However, MGSA was considerably less potent than NAP-1/IL-8 in inducing the respiratory burst. Intradermal injections in rats of MGSA resulted in a massive accumulation of neutrophils . Our data demonstrate that, apart from its growth-stimulatory activity, MGSA is a potent inflammatory agonist with neutrophil-stimulating properties .
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